"Szemészeti magánrendelés Pécs belvárosában."

During the past decade, Ganglion Medial Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 10 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ganglion Medial Center" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "IVERIC bio, Inc." with 2 trials sponsored, "Aerie Pharmaceuticals" with 1 trials sponsored, "Alkahest, Inc." with 1 trials sponsored and "Allergan" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ganglion Medial Center" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ganglion Medial Center" are "Geographic Atrophy" (5 trials), "Diabetic Macular Edema" (3 trials), "Diabetic Retinopathy" (2 trials), "Macular Degeneration" (2 trials) and "Macular Edema" (2 trials). Many other conditions were trialed in "Ganglion Medial Center" in a lesser frequency.

Most popular intervention types in "Ganglion Medial Center" are "Drug" (17 trials), "Other" (8 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (5 trials), "Faricimab" (5 trials), "Sham Procedure" (5 trials), "Lampalizumab" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ganglion Medial Center" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Ganglion Medial Center". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ganglion Medial Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Ganglion Medial Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".